Official Gene Symbol | Other Aliases |
---|---|
PRKCB | PKCB, PRKCB1 |
Sequence Length (AA) | Molecular Weight (Da) |
---|---|
671 | 76869 |
Protein Name |
---|
Protein kinase C beta type |
Sources | |
---|---|
UniProt PhosphoSitePlus ® GeneCards |
Human Protein Atlas |
10 | 20 | 30 | 40 | 50 |
MADPAAGPPP | SEGEESTVRF | ARKGALRQKN | VHEVKNHKFT | ARFFKQPTFC |
60 | 70 | 80 | 90 | 100 |
SHCTDFIWGF | GKQGFQCQVC | CFVVHKRCHE | FVTFSCPGAD | KGPASDDPRS |
110 | 120 | 130 | 140 | 150 |
KHKFKIHTYS | SPTFCDHCGS | LLYGLIHQGM | KCDTCMMNVH | KRCVMNVPSL |
160 | 170 | 180 | 190 | 200 |
CGTDHTERRG | RIYIQAHIDR | DVLIVLVRDA | KNLVPMDPNG | LSDPYVKLKL |
210 | 220 | 230 | 240 | 250 |
IPDPKSESKQ | KTKTIKCSLN | PEWNETFRFQ | LKESDKDRRL | SVEIWDWDLT |
260 | 270 | 280 | 290 | 300 |
SRNDFMGSLS | FGISELQKAS | VDGWFKLLSQ | EEGEYFNVPV | PPEGSEANEE |
310 | 320 | 330 | 340 | 350 |
LRQKFERAKI | SQGTKVPEEK | TTNTVSKFDN | NGNRDRMKLT | DFNFLMVLGK |
360 | 370 | 380 | 390 | 400 |
GSFGKVMLSE | RKGTDELYAV | KILKKDVVIQ | DDDVECTMVE | KRVLALPGKP |
410 | 420 | 430 | 440 | 450 |
PFLTQLHSCF | QTMDRLYFVM | EYVNGGDLMY | HIQQVGRFKE | PHAVFYAAEI |
460 | 470 | 480 | 490 | 500 |
AIGLFFLQSK | GIIYRDLKLD | NVMLDSEGHI | KIADFGMCKE | NIWDGVTTKT |
510 | 520 | 530 | 540 | 550 |
FCGTPDYIAP | EIIAYQPYGK | SVDWWAFGVL | LYEMLAGQAP | FEGEDEDELF |
560 | 570 | 580 | 590 | 600 |
QSIMEHNVAY | PKSMSKEAVA | ICKGLMTKHP | GKRLGCGPEG | ERDIKEHAFF |
610 | 620 | 630 | 640 | 650 |
RYIDWEKLER | KEIQPPYKPK | ARDKRDTSNF | DKEFTRQPVE | LTPTDKLFIM |
660 | 670 | 671 | ||
NLDQNEFAGF | SYTNPEFVIN | V |
Data source: UniProt
Uniprot Database Entry PhosphoSitePlus ®
loading
Data source: Panorama
View Details (opens in a new window)
Abelin, et al. Mol Cell Proteomics. 2016 May;15(5):1622-41. doi: 10.1074/mcp.M116.058354. Epub 2016 Feb 24. PMID:26912667
Data source: Panorama
Broad Institute-Biologist curated set of targets across a number of important cancer pathways
Data source: Panorama
Data source: Panorama
Retrieving Data
Data source: Panorama
Average intra-assay CV (within day CV) |
Average inter-assay CV (between day CV) |
Total CV |
n= | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High |
y6 (1+) | 48.5 | 29 | 33.5 | 54.7 | 28.5 | 47.3 | 73.1 | 40.7 | 58 | 15 | 15 | 15 |
y5 (1+) | 45.7 | 35.9 | 24.9 | 78.2 | 37.6 | 53.9 | 90.6 | 52 | 59.4 | 15 | 15 | 15 |
y4 (1+) | 23.2 | 20.4 | 15.4 | 25 | 21.5 | 16.2 | 34.1 | 29.6 | 22.4 | 15 | 15 | 15 |
sum | 20.4 | 10.7 | 15 | 18.8 | 12.4 | 20.3 | 27.7 | 16.4 | 25.2 | 15 | 15 | 15 |
Data source: Panorama
Data source: Panorama
Broad Institute-Biologist curated set of targets across a number of important cancer pathways
Data source: Panorama
Data source: Panorama
Retrieving Data
Data source: Panorama
Average intra-assay CV (within day CV) |
Average inter-assay CV (between day CV) |
Total CV |
n= | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High |
y5 (1+) | 4.2 | 6.5 | 4.5 | 6.9 | 5.1 | 7.5 | 8.1 | 8.3 | 8.7 | 15 | 15 | 15 |
y3 (1+) | 9.1 | 4.6 | 5.4 | 5 | 4.4 | 7.9 | 10.4 | 6.4 | 9.6 | 15 | 15 | 15 |
y7 (1+) | 3.8 | 5.2 | 4.9 | 3.5 | 4.3 | 7.3 | 5.2 | 6.7 | 8.8 | 15 | 15 | 15 |
sum | 4.2 | 5 | 4.6 | 3.9 | 4 | 7.1 | 5.7 | 6.4 | 8.5 | 15 | 15 | 15 |
Data source: Panorama
Data source: Panorama
Broad Institute-Biologist curated set of targets across a number of important cancer pathways
Data source: Panorama
Data source: Panorama
Retrieving Data
Data source: Panorama
Average intra-assay CV (within day CV) |
Average inter-assay CV (between day CV) |
Total CV |
n= | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High |
y7 (1+) | 7.1 | 5.8 | 3.6 | 7.7 | 5.5 | 4 | 10.5 | 8 | 5.4 | 15 | 15 | 15 |
y4 (1+) | 8.5 | 8.9 | 11.8 | 11.2 | 15.7 | 18.2 | 14.1 | 18 | 21.7 | 15 | 15 | 15 |
y3 (1+) | 8 | 7.2 | 6.1 | 9.5 | 10.1 | 7.1 | 12.4 | 12.4 | 9.4 | 15 | 15 | 15 |
sum | 6.4 | 5.9 | 6.2 | 8.2 | 9.3 | 9.2 | 10.4 | 11 | 11.1 | 15 | 15 | 15 |
Comments